Antibiotic susceptibility pattern of Staphylococcus aureus in tertiary care hospital, SRMSIMS, Bareilly, U.P.

Vaishali Gupta; Ravi Pachori; Rahul Kumar Goyal

doi:10.18203/2394-6040.ijcmph20173327

Authors

Vaishali Gupta Department of Microbiology, HIMS, Mau, Ataria, Sitapur, Uttar Pradesh, India
Ravi Pachori Department of Community Medicine, HIMS, Mau, Ataria, Sitapur, Uttar Pradesh, India
Rahul Kumar Goyal Department of Microbiology, SRMSIMS, Bareilly, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20173327

Keywords:

S. aureus, MSSA, MRSA, VISA, VRSA

Abstract

Background: S. aureus has been recognized as continuously challenging the clinicians despite the availability of antibiotics from nearly 70 yrs and emergence of various types of antibiotic resistance mechanisms especially to methicillin and vancomycin, which was the theme of this study. The study was to determine the antibiotic susceptibility of Staphylococcus aureus in Tertiary Care Hospital, SRMSIMS, Bareilly and also to determine the current status of Vancomycin susceptibility in our Hospital setup considering E-Test as gold standard.

Methods: This study was prospective in design from 1st January 2014 to 31st December 2014 and conducted in the Department of Microbiology, SRMSIMS, Bareilly. All S. aureus strains were screened for vancomycin resistance by Dual strip E- test.

Results: Out of 505 Staphylococcus aureus isolates, we found that MRSA, VISA, and VRSA as 80.8%, 0.6% and 0.0% respectively. In cases of MRSA, antibiogram showed sensitivity in the range of 99.4 -100% for glycopeptides, and sensitivity to levofloxacin, chloramphenicol was 77.5% and 65.2% respectively.

Conclusions: On evaluation of MIC by E-strips, we found that 17% of MRSA were showing MIC values quite near to the MIC value of VISA. So, these strains may convert to VISA, if the injudicious use of vancomycin antibiotics is not stopped.

Metrics

Metrics Loading ...

Author Biography

Vaishali Gupta, Department of Microbiology, HIMS, Mau, Ataria, Sitapur, Uttar Pradesh, India

Assistant Professor & DMS, Department of Community Medicine, HIMS, Mau, Ataria, Sitapur, Uttar Pradesh, India

References

Lowy FD. Staphylococcus aureus infection. New Engl Jour Med. 1998;339:520-32.

Waldvogel FA. Staphylococcus aureus. In: Mandell GL, Bennett JE, Dolun R, Livingstone C, editors. In principles and practice of infectious diseases. Philadelphia Pennsyl vania USA; 2000: 2069-2092.

Kapil A, Sharma A, Thomas PA, editors. Ananthanarayan & Paniker’s Textbook of Microbiology, 9th Edition. Universities Press; 2013: 199-207.

Elmer K, Washington W, Staphen A, Gary P, editors. Color Atlas & Textbook of Diagnostic Microbiology, 6th edition. Wolters Kluwer; 2006: 643–648.

Boucher HW. Challenges in anti-infective development in the era of bad bugs, no drugs: A regulatory perspective using the example of BSI as an indication, Clin Infect Dis. 2010;50:S4-9.

Ratnaraja NV, Hawkey PM. Current challenges in treating MRSA: What are the options? Expert Rey Anti-Infect Therapy. 2008;6:601-18.

Patel AK, Patel KK, Patel KR, Shah S, Dileep P. Time trend epidemiology of microbial infections at a tertiary care center in west India over last 5 years. J Assoc Physicians India. 2010;58 Suppl:37-40.

Gopalakrishnan R, Sureshkumar D. Changing trends in antimicrobial susceptibility and hospital acquired infections over an 8 year period in a tertiary care hospital in relation to introduction of an infection control programme. J Assoc Physicians India. 2010;58 Suppl:25-31.

Thati V, Shivannavar CT, Gaddad SM. Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res. 2011;134(5):704–8.

Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. Infect Dis. 2006;6:156.

Joshi S, Ray P, Manchanda V, Bajaj J, Chitnis DS, Gautam V. Indian network for surveillance of Antimicrobial Resistance (INSAR) Group, India. Methicillin resistant Staphylococcus aureus (MRSA) in India: Prevalence & susceptibility pattern. Indian J Med Res. 2013;137(2):363–9.

Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM. Prevalence of methicillin resistant Staphylococcus aureus in tertiary referral hospital in Eastern Uttar Pradesh. Indian J Med Microbiol. 2003;21(1):49-51.

Verma S, Joshi S, Chitnis V. Growing problem of Methicillin resistant Staphylococci: Indian Scenario. Ind Jour Med Sci. 2000;54(12):535-40.

Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, Golmard JL, Jarlier V, et al. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabetic Med. 2004;21:710–5.

Centers for Disease Control and Prevention Staphylococcus aureus resistant to vancomycin-United States, 2002. Morb Mortal Wkly Rep. 2002;51:565-7.

Kuklin NA, Clark DJ, SecoreS, CookJ, Cope LD, et al. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun. 2006;74:2215–23.

Gupta MK, Banerjee T, Anupurba S, Tilak R. Changing trend in susceptibility to vancomycin of methicillin susceptible and resistant Staphylococcus aureus clinical isolates from a tertiary care centre. Indian J Pathol Microbiol. 2014;57:662-3.

Chaudhary U, Anupama. Prevalence of Methicillin resistance in Staphylococcus aureus. Indian J Med Microbiol. 1999;17(3):154-5.

Anvikar AR, Deshmukh AB, Karyakarte RP, Damle AS, Patwardhan NS, Malik AK, et al. A one year prospective study of 3,280 surgical wounds. Indian Jour Med Microbiol 1999;17:129-132.

Majumder D, Sarma Bordoloi JN, Phukan AC. Antimicrobial susceptibility pattern among methicillin resistant Staphylococcus isolates in Assam. Indian J Med Microbiol. 2001;19(3):21-7.

Hanumanthappa AR, Chandrappa NR, Rajasekharappa MG. Prevalence of methicillin resistant Staphylococcus aureus in Karnataka. Indian J Pathol Microbiol. 2003;46(1):129-32.

Pulimood TB, Lalitha MK, Jesudason MV, Pandian R, Selwyn J, John TJ. The spectrum of antimicrobial resistance among MRSA in a tertiary care center in India. Indian J Med Res. 1996;103:212-5.

Thouverez M, Muller A, Hocquet D, Talon D, Bertrand X. Relationship between molecular epidemiology and antibiotic susceptibility of methicillin resistant Staphylococcus aureus in a French teaching hospital. J Clin Microbiol. 2003;52:801-6.

Stevens DL, Smith LG, Bruss JB. Randomized comparison of Linezolid versus oxacillin-dicloxacillin treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother. 2000;43:3408-13.

Tsiodras S, Gold HS, Sakoulas G. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet. 2001;358:207-8.

Boucher HW, Corey GR, Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008,46(Suppl 5):S344-9.

Tenover FC. Staphylococcal susceptibility testing: new challenges. Program of the 38th interscience conference on antimicrobial agents and chemotherapy. Washington DC. American Society for Microbiology 1998: 3.

Clinical and Laboratory Standards Institute [CLSI]. Performance Standards for Antimicrobial Susceptibility Testing. Twenty- second Informational Supplement. M100-S22. 2012; 32(1).

Centers for Disease Control and Prevention. Investigation and Control of Vancomycin-Intermediate and Resistant Staphylococcus aureus (VISA/VRSA). A Guide for Health Departments and Infection Control Personnel.

Hsu DI, Hidayat LK, Quist R, Hindler J, Karlsson A, Yusof A, et al. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of methicillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents. 2008;32:378-85.

Hiramatsu K, Hanaki H, Ino T, Oguri YT, Tenover FC. Methicillin resistant Staphylococcus aureus clinical strain with reduced susceptibility. J Antimicrob Chemother. 1997;40:135-6.

Biswajit S, Anil KS, Abhrajyoti G, Manjusri B et al. Identification and characterization of a vancomycin- resistant Staphylococcus aureus isolated from Kolkata (South Asia). J Med Microbiol. 2008;57:72–9.

Menezes GA, Harish BN, Sujatha S, Vinothini K, Parija SC. Emergence of vancomycin-intermediate Staphylococcus species in southern India. J Med Microbiol. 2008;911-2.

Kakru DK, Assadullah S, Thoker MA, Wani T. Methicillin resistant Staphylococcus aureus: need for constant surveillance, stringent control and vigorous treatment measures. Indian J Pathol Microbiol. 2003;46(1):121-3.

Vidhani S, Mehndiratta PL, Mathur MD. Study of methicillin resistant S.aureus isolates from high risk patients. Ind J Med Microbiol. 2001;19(2):87-90.

Roveta S, Tonoli E, Marchese A, Schito GC. Epidemiology of methicillin resistance among staphylococcal strains isolated in risk units and effects of the vancomycin on the expression of methicillin resistance. Infez Med. 2001;9(2):82-9.

Siddiqi F, Masood MB, Saba N, Samad A, Qayyum M, Qazilbash AA. Antibiogram sensitivity pattern of methicillin resistant Staphylococcus aureus isolates from pus samples. Pakistan J Biological Sci. 2002;5(4):491-3.

Mehta A, Rodrigues C, Kumar R, et al. A pilot programme of MRSA surveillance in India (MRSA Surveillance Study group). Postgrad Med J. 1996;42(1):1-3.

Neoh HM, Hori S, Komatsu M, Oguri T, Takeuchi F, Cui L, et al. Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections. Ann Clin Microbiol Antimicrob. 2007;6:13.